Reference number : 172-2018-2019-Q3-915674, amendment number : , agreement type : C, recipient legal name : RAZn Health Decision Modelling Ltd., recipient country : CA, recipient province : AB, recipient city : Edmonton|Edmonton, recipient postal code : T5J 4P6, program name english : Industrial Research Assistance Program – Contributions to Firms, program name french : Programme d’aide à la recherche industrielle – Contributions aux entreprises, program purpose english : The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization, program purpose french : Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation, agreement title english : Value Engineered Translation for Healthcare and Biotechnology Industry, agreement title french : Traduction optimisée pour le secteur de la santé et de la biotechnologie, agreement number : 915674, agreement value : 37800.0, agreement start date : 2018-11-15, agreement end date : 2019-10-15, description english : Clinical adoption of cell-based treatments is hampered due to the complexity of cell and tissue
based therapies compared with small molecules and other drugs, uncertainty in treatment
outcomes, a cautious and evolving regulatory process, and lack of proven models of
transnational research. We have previously developed an innovative multidisciplinary decision model and value of information analysis framework for cell-based immunotherapies to guide investment decisions in regenerative medicine and inform emerging regulatory
frameworks.The goal is to target all manufacturing models of cell-based therapies (autologus and allogeneic) which have proven difficult to successfully translate into marketable product., description french : Traduction optimisée pour le secteur de la santé et de la biotechnologie, expected results english : The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization, expected results french : Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation, additional information english : nan, additional information french : nan, owner organization : nrc-cnrc, owner organization title : National Research Council Canada | Conseil national de recherches Canada